|Podcasts|August 5, 2022

Intertwining Technology and Data Solutions

A look into the effectiveness of data processing pipelines

Michael Swartz, SVP of Enterprise Product Strategy for Dotmatics, an R&D scientific software company, discusses the impact that the “data deluge” is having on biopharma companies, along with what the “lab of the future” shapes up to be in his eyes.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.


Related to this article

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | © Tada Images - stock.adobe.com 521699065
In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.
CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.